Chad vs Kazakhstan: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Chad
49.0%
in 2025
Kazakhstan
49.0%
in 2025
Chad rank
156th
Kazakhstan rank
156th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Chad
- Kazakhstan
How they compare
Chad currently reports 49.0% against 49.0% in Kazakhstan, a difference of 0.0%.
Across all 18 years both countries report, Kazakhstan has been ahead every year.
Chad ranks 156th and Kazakhstan ranks 156th of 194 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 51.4% | 51.4% | Kazakhstan |
| 2020s | 8.2% | 50.8% | 42.7% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Chad or Kazakhstan?
- Chad, at 49.0% against 49.0% in Kazakhstan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Chad and Kazakhstan?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Kazakhstan?
- 18 years are reported by both, from 2008 to 2025.
- How do Chad and Kazakhstan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Chad ranks 156th and Kazakhstan ranks 156th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.